FEMASYS INC

Femasys is a biomedical company that develops and commercializes a portfolio of patent-protected medical devices addressing unmet needs in women's health, particularly in infertility treatment and permanent birth control. The company manufactures in-office diagnostic and therapeutic products including FemaSeed for intratubal insemination, FemVue for fallopian tube assessment, and FemBloc for non-surgical permanent contraception, marketed primarily to gynecologists and reproductive specialists in North America and key international markets. Femasys generates revenue from the sale of these devices to medical practices, with infertility products typically purchased directly by patients due to variable insurance coverage, while permanent birth control products are expected to be reimbursed by third-party payors including Medicare, Medicaid, and private insurers.